Clearance of cationized LDL cholesterol from a muscle depot is not enhanced in human apolipoprotein A-IV transgenic mice

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 1, 2000, Pages 179-184

  Stein, Y ^a   Stein, O ^b   Duverger, N ^c   Halperin, G ^a   Dabach, Y ^a   Hollander, G ^d   Ben Naim, M ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY   (Israel)

^c SANOFI   (France)

^d Sheba Hospital   (Israel)

Author keywords

Apolipoprotein A IV; High density lipoprotein; Lecithin cholesterol acyltransferase; Phospholipids; Reverse cholesterol transport

Indexed keywords

APOLIPOPROTEIN A4; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PHOSPHOLIPID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL ESTERIFICATION; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; FEMALE; MALE; MUSCLE; NONHUMAN; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; RAT; TRANSGENIC MOUSE;

EID: 0033971973     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.1.179     Document Type: Article

References (37)

1. Beisiegel U, Utermann G. An apolipoprotein homolog of rat apolipoprotein A-IV in human plasma: isolation and partial characterisation. Eur J Biochem. 1979;93:601-608.
2. Green PH, Glickman RM, Riley JW, Quinet E. Human apolipoprotein A-IV: intestinal origin and distribution in plasma. J Clin Invest. 1980;65: 911-919.
3. Fidge NH. The redistribution and metabolism of iodinated apolipoprotein A-IV in rats. Biochim Biophys Acta. 1980;619:129-141.
4. DeLamatre JG, Hoffmeier CA, Lacko AG, Roheim PS. Distribution of apolipoprotein A-IV between the lipoprotein and the lipoprotein-free fractions of rat plasma: possible role of lecithin:cholesterol acyltransferase. J Lipid Res. 1983;24:1578-1585.
5. Dory L, Boquet LM, Hamilton RL, Sloop CH, Roheim PS. Heterogeneity of dog interstitial fluid (peripheral lymph) high density lipoprotems: implications for a role in reverse cholesterol transport. J Lipid Res. 1985;26:519-527.
6. Stein O, Stein Y, Lefevre M, Roheim PS. The role of apolipoprotein A-IV in reverse cholesterol transport studied with cultured cells and liposomes derived from an ether analog of phosphatidylcholine. Biochim Biophys Acta. 1986;878:7-13.
7. Steinmetz A, Barbaras R, Ghalim N, Clavey V, Fruchart JC, Ailhaud G. Human apolipoprotein A-IV binds to apolipoprotein A-I/A-II receptor sites and promotes cholesterol efflux from adipose cells. J Biol Chem. 1990;265:7859-7863.
8. Duverger N, Ghalim N, Ailhaud G, Steinmetz A, Fruchart JC, Castro G. Characterization of apoA-IV-containing lipoprotein particles isolated from human plasma and interstitial fluid. Arterioscler Thromb. 1993;13: 126-132.
9. Aalto-Setala K, Bisgaier CL, Ho A, Kieft KA, Traber MG, Kayden HJ, Ramakrishnan R, Walsh A, Essenburg AD, Breslow JL. Intestinal expression of human apolipoprotein A-IV in transgenic mice fails to influence dietary lipid absorption or feeding behavior. J Clin Invest. 1994;93:1776-1786.
10. Cohen RD, Castellani LW, Qiao JH, Van Lenten BJ, Lusis AJ, Reue K. Reduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein A-IV. J Clin Invest. 1997;99:1906-1916.
11. Duverger N, Tremp G, Caillaud JM, Emmanuel F, Castro G, Fruchart JC, Steinmetz A, Denefle P. Protection against atherogenesis in mice mediated by human apolipoprotein A-IV. Science. 1996;273:966-968.
12. Stein O, Dabach Y, Hollander G, Ben-Naim M, Halperin G, Okon E, Stein Y. Cholesterol efflux in vivo from a depot of cationized LDL injected into a thigh muscle of small rodents. Atherosclerosis. 1997;133: 15-22.
13. Stein O, Dabach Y, Hollander G, Ben-Naim M, Halperin G, Breslow JL, Stein Y. Delayed loss of cholesterol from a localized lipoprotein depot in apolipoprotein A-I-deficient mice. Proc Natl Acad Sci U S A. 1997;98: 9820-9824.
14. Simonet WS, Bucay N, Lauer SJ, Taylor JM. A far-downstream hepatocyte-specific control region directs expression of the linked human apolipoprotein E and C-I genes in transgenic mice. J Biol Chem. 1993;268: 8221-8229.
15. Pruvot I, Fievet C, Durieux C, Vu DN, Fruchart J. Electroimmuno- and immuno-nephelometric assays of apolipoprotein A-I by using a mixture of monoclonal antibodies. Clin Chem. 1988;34:2048-2052.
16. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1995;34:1345-1353.
17. Basu SK, Goldstein JL, Anderson RGW, Brown MS. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. Proc Natl Acad Sci U S A. 1976;73:3178-3182.
18. Folch J, Lees M, Sloane-Stanley GH. A simple method for the isolation and purification of total lipids from animal tissue. J Biol Chem. 1957; 226:497-509.
19. Ohta T, Nakamura R, Takata K, Saito Y, Yamashita S, Horiuchi S, Matsuda T. Structural and functional differences of subspecies of apoA-I-containing lipoprotein in patients with plasma cholesteryl ester transfer protein deficiency. J Lipid Res. 1995;36:696-704.
20. Friedman G, Gallily R, Chajek-Shaul T, Stein O, Shiloni E, Etienne J, Stein Y. Lipoprotein lipase in heart cell cultures is suppressed by bacterial lipopolysaccharide: an effect mediated by production of tumor necrosis factor. Biochim Biophys Acta. 1988;960:220-228.
21. 3H]cholesterol efflux and uptake in cell culture. Biochim Biophys Acta. 1995;1257:174-180.
22. Stein O, Dabach Y, Hollander G, Ben-Naim M, Halperin G, Stein Y. High levels of human apolipoprotein A-I and HDL in transgenic mice do not enhance efflux of cholesterol from a depot of injected lipoproteins: relevance to regression of atherosclerosis? Atherosclerosis. 1999;144: 367-374.
23. Woollett LA, Spady DK. Kinetic parameters for high density lipoprotein apoprotein AI and cholesteryl ester transport in the hamster. J Clin Invest. 1997;99:1704-1713.
24. -/- mouse. J Lipid Res. 1998;39:1483-1492.
25. Castro G, Nihoul LP, Dengremont C, de Geitere C, Delfly B, Tailleux A, Fievet C, Duverger N, Denefle P, Fruchart J-C, Rubin EM. Cholesterol efflux, lecithin-cholesterol acyltransferase activity, and pre-β particle formation by serum from human apolipoprotein A-I and apolipoprotein A-I/apolipoprotein A-II transgenic mice consistent with the latter being less effective for reverse cholesterol transport. Biochemistry. 1997;36: 2243-2249.
26. Lefevre M, Goudey-Lefevre JC, Roheim PS. Preferential redistribution ot lipoprotein-unassociated apoA-IV to an HDL subpopulation with a high degree of LCAT modification. Lipids. 1989;24:1035-1038.
27. Jonas A, Sweeny SA, Herbert PN. Discoidal complexes of A and C apolipoproteins with lipids and their reactions with lecithin:cholesterol acyltransferase. J Biol Chem. 1984;259:6369-6375.
28. Steinmetz A, Utermann G. Activation of lecithin:cholesterol acyltransferase by human apolipoprotein A-IV. J Biol Chem. 1985;260: 2258-2264.
29. Chen CH, Albers JJ. Activation of lecithin:cholesterol acyltransterase by apolipoproteins E-2, E-3, and A-IV isolated from human plasma. Biochim Biophys Acta. 1985;836:279-285.
30. Duverger N, Ghalim N, Theret N, Fruchart JC, Castro G. Lipoproteins containing apolipoprotein A-IV: composition and relation to cholesterol esterification. Biochim Biophys Acta. 1994;1211:23-28.
31. Glomset JA. The plasma lecithin:cholesterol acyltransferase reaction. J Lipid Res. 1968;9:155-167.
32. Fielding CJ, Fielding PE. Molecular physiology of reverse cholesterol transport. J Lipid Res. 1995;36:211-228.
33. Stein O, Goren R, Stein Y. Removal of cholesterol from fibroblasts and smooth muscle cells in culture in the presence and absence of cholesterol esterification in the medium. Biochim Biophys Acta. 1978;529:309-318.
34. Czarnecka H, Yokoyama S. Lecithin:cholesterol acyltransferase reaction on cellular lipid released by free apolipoprotein-mediated efflux. Biochemistry. 1995;34:4385-4392.
35. Mackness MI, Arros S, Durrington PN. Paraoxonase prevents accumulation of lipoperoxides in low density lipoprotein. FEBS Lett. 1991;286: 152-154.
36. Qin X, Swertfeger DK, Zhen S, Hui DY, Tso P. Apolipoprotein AIV: a potent endogenous inhibitor of lipid oxidation. Am J Physiol. 1998;274: H1836-H1840.
37. Tangirala RK, Tsukamoto K, Chun S, Pure E, Rader DJ. Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I. Circulation. 1998;98:1-251.